Stephen Kanes - 15 Jun 2021 Form 4 Insider Report for Sage Therapeutics, Inc. (SAGE)

Role
Chief Medical Officer
Signature
/s/ Jennifer Fitzpatrick, as Attorney-in-Fact for Stephen Kanes
Issuer symbol
SAGE
Transactions as of
15 Jun 2021
Net transactions value
-$58,859
Form type
4
Filing time
17 Jun 2021, 09:12:29 UTC
Next filing
21 Oct 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SAGE Common Stock Award $0 +3,500 +42% $0.000000 11,792 15 Jun 2021 Direct F1
transaction SAGE Common Stock Tax liability $58,859 -1,001 -8.5% $58.80 10,791 15 Jun 2021 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On March 25, 2020, the reporting person was granted Performance Stock Units (PSU) to acquire a total of 8,750 shares of common stock. The PSU vests upon the achievement of certain milestones, one of which was met on June 15, 2021, resulting in the vesting of the PSU as to 3,500 shares.